// App-Quantinova.ai

62 : Stem-Cell Transplantation in Adults with Philadelphia-Negative High-Risk Acute Lymphoblastic Leukemia in First Complete Remission: A Prospective Multicenter Trial Comparing Haploidentical Donors with Identical Sibling Donors

Researchers

Presenter

  • Yu Wang

Principal Investigators

  • Wu Depei

  • Qifa Liu

  • Lan-Ping Xu

  • Xiao-Hui Zhang

  • Xiao-Jun Huang

Medical Centers

  • Peking University Peoples Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China

  • Department of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China

  • Peking University Institute of Haematology, Peoples Hospital, Beijing, China

  • Dept. of Hematology, The First Affiliated Hosp. of Suzhou, Suzhou, China

Locations

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

Disease

  • Acute lymphoblastic leukemia

  • Graft-versus-host disease

  • Hyperimmunoglobulinemia D and periodic fever syndrome

Biomarkers

  • Breakpoint Cluster Region

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved